AKT1 and type 1 diabetes mellitus: Furthermore, it has been demonstrated that γ-aminobutyric acid in islet β cell could activate phosphatidylinositol 3-kinase/protein kinase B (PI3-K/Akt)–dependent growth and survival pathways, which provides a potential therapy to preserve β-cell mass and prevent the development of T1D [136].